Literature DB >> 26787841

MicroRNA 211 Functions as a Metabolic Switch in Human Melanoma Cells.

Joseph Mazar1, Feng Qi1, Bongyong Lee1, John Marchica1, Subramaniam Govindarajan1, John Shelley1, Jian-Liang Li1, Animesh Ray2, Ranjan J Perera3.   

Abstract

MicroRNA 211 (miR-211) negatively regulates genes that drive invasion of metastatic melanoma. Compared to normal human melanocytes, miR-211 expression is significantly reduced or absent in nonpigmented melanoma cells and lost during human melanoma progression. To investigate the molecular mechanism of its tumor suppressor function, miR-211 was ectopically expressed in nonpigmented melanoma cells. Ectopic expression of miR-211 reduced hypoxia-inducible factor 1α (HIF-1α) protein levels and decreased cell growth during hypoxia. HIF-1α protein loss was correlated with the downregulation of a miR-211 target gene, pyruvate dehydrogenase kinase 4 (PDK4). We present evidence that resumption of miR-211-mediated downregulation of PDK4 in melanoma cells causes inhibition of invasion by nonpigmented melanomas via HIF-1α protein destabilization. Thus, the tumor suppressor miR-211 acts as a metabolic switch, and its loss is expected to promote cancer hallmarks in human melanomas. Melanoma, one of the deadliest forms of skin cancer, kills nearly 10,000 people in the United States per year. We had previously shown that a small noncoding RNA, termed miR-211, suppresses invasion and the growth of aggressive melanoma cells. The results presented here support the hypothesis that miR-211 loss in melanoma cells causes abnormal regulation of energy metabolism, which in turn allows cancer cells to survive under low oxygen concentrations-a condition that generally kills normal cells. These findings highlight a novel mechanism of melanoma formation: miR-211 is a molecular switch that is turned off in melanoma cells, raising the hope that in the future we might be able to turn the switch back on, thus providing a better treatment option for melanoma.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26787841      PMCID: PMC4800793          DOI: 10.1128/MCB.00762-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  21 in total

1.  Role of TRPM in melanocytes and melanoma.

Authors:  Huazhang Guo; John Andrew Carlson; Andrzej Slominski
Journal:  Exp Dermatol       Date:  2012-09       Impact factor: 3.960

Review 2.  Alterations in bioenergetics due to changes in mitochondrial DNA copy number.

Authors:  Wei Qian; Bennett Van Houten
Journal:  Methods       Date:  2010-03-25       Impact factor: 3.608

3.  Downregulation of microRNA-211 is involved in expression of preferentially expressed antigen of melanoma in melanoma cells.

Authors:  Eiichi Sakurai; Chihaya Maesawa; Masahiko Shibazaki; Shinji Yasuhira; Hiroki Oikawa; Masayuki Sato; Kanako Tsunoda; Yuichi Ishikawa; Ayano Watanabe; Kazuhiro Takahashi; Toshihide Akasaka; Tomoyuki Masuda
Journal:  Int J Oncol       Date:  2011-06-16       Impact factor: 5.650

4.  Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma.

Authors:  Carmit Levy; Mehdi Khaled; Dimitrios Iliopoulos; Maja M Janas; Steffen Schubert; Sophie Pinner; Po-Hao Chen; Shuqiang Li; Anne L Fletcher; Satoru Yokoyama; Kenneth L Scott; Levi A Garraway; Jun S Song; Scott R Granter; Shannon J Turley; David E Fisher; Carl D Novina
Journal:  Mol Cell       Date:  2010-11-25       Impact factor: 17.970

5.  Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.

Authors:  Glen M Boyle; Susan L Woods; Vanessa F Bonazzi; Mitchell S Stark; Elke Hacker; Lauren G Aoude; Ken Dutton-Regester; Anthony L Cook; Richard A Sturm; Nicholas K Hayward
Journal:  Pigment Cell Melanoma Res       Date:  2011-04-07       Impact factor: 4.693

6.  Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect.

Authors:  David A Scott; Adam D Richardson; Fabian V Filipp; Christine A Knutzen; Gary G Chiang; Ze'ev A Ronai; Andrei L Osterman; Jeffrey W Smith
Journal:  J Biol Chem       Date:  2011-10-13       Impact factor: 5.157

7.  Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation.

Authors:  Bin Zheng; Joseph H Jeong; John M Asara; Yuan-Ying Yuan; Scott R Granter; Lynda Chin; Lewis C Cantley
Journal:  Mol Cell       Date:  2009-01-30       Impact factor: 17.970

8.  The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.

Authors:  Joseph Mazar; Katherine DeYoung; Divya Khaitan; Edward Meister; Alvin Almodovar; James Goydos; Animesh Ray; Ranjan J Perera
Journal:  PLoS One       Date:  2010-11-01       Impact factor: 3.240

9.  Hypoxia induces PDK4 gene expression through induction of the orphan nuclear receptor ERRγ.

Authors:  Ja Hee Lee; Eun-Jin Kim; Don-Kyu Kim; Ji-Min Lee; Seung Bum Park; In-Kyu Lee; Robert A Harris; Mi-Ock Lee; Hueng-Sik Choi
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

10.  Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.

Authors:  Y Xu; T Brenn; E R S Brown; V Doherty; D W Melton
Journal:  Br J Cancer       Date:  2012-01-05       Impact factor: 7.640

View more
  35 in total

1.  Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing.

Authors:  Sankhiros Babapoor; Rong Wu; James Kozubek; Donna Auidi; Jane M Grant-Kels; Soheil S Dadras
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

2.  Transcriptome stability profiling using 5'-bromouridine IP chase (BRIC-seq) identifies novel and functional microRNA targets in human melanoma cells.

Authors:  Piyush Joshi; Tatsuya Seki; Shinobu Kitamura; Andrea Bergano; Bongyong Lee; Ranjan J Perera
Journal:  RNA Biol       Date:  2019-06-16       Impact factor: 4.652

Review 3.  MicroRNA regulation and analytical methods in cancer cell metabolism.

Authors:  Ling-Fei Zhang; Shuai Jiang; Mo-Fang Liu
Journal:  Cell Mol Life Sci       Date:  2017-03-20       Impact factor: 9.261

4.  MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo.

Authors:  Anupama Sahoo; Bongyong Lee; Katia Boniface; Julien Seneschal; Sanjaya K Sahoo; Tatsuya Seki; Chunyan Wang; Soumen Das; Xianlin Han; Michael Steppie; Sudipta Seal; Alain Taieb; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2017-05-11       Impact factor: 8.551

5.  miRNA-211 stops the clock.

Authors:  Carmit Levy; Tamar Golan; David E Fisher
Journal:  Noncoding RNA Investig       Date:  2018-05-06

Review 6.  Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.

Authors:  Sébastien Bonnet; Olivier Boucherat; Roxane Paulin; Danchen Wu; Charles C T Hindmarch; Stephen L Archer; Rui Song; Joseph B Moore; Steeve Provencher; Lubo Zhang; Shizuka Uchida
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-04       Impact factor: 4.249

7.  miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma.

Authors:  Marta Díaz-Martínez; Lucía Benito-Jardón; Lola Alonso; Lisa Koetz-Ploch; Eva Hernando; Joaquin Teixidó
Journal:  Cancer Res       Date:  2017-12-11       Impact factor: 12.701

8.  Targeting PDK4 inhibits breast cancer metabolism.

Authors:  Maheedhara R Guda; Swapna Asuthkar; Collin M Labak; Andrew J Tsung; Ilya Alexandrov; Malcolm J Mackenzie; Durbaka Vr Prasad; Kiran K Velpula
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

9.  BRAFV600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells.

Authors:  Taral R Lunavat; Lesley Cheng; Berglind O Einarsdottir; Roger Olofsson Bagge; Somsundar Veppil Muralidharan; Robyn A Sharples; Cecilia Lässer; Yong Song Gho; Andrew F Hill; Jonas A Nilsson; Jan Lötvall
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-06       Impact factor: 11.205

10.  MicroRNA-211 Loss Promotes Metabolic Vulnerability and BRAF Inhibitor Sensitivity in Melanoma.

Authors:  Anupama Sahoo; Sanjaya K Sahoo; Piyush Joshi; Bongyong Lee; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2018-08-01       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.